ArticleNature communications2025

Vancomycin heteroresistance (hVISA) in MRSA links to treatment failure and supports a revised PAP-AUC threshold.

Nikos Fatsis-Kavalopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.